NewAge, Inc.

NBEV Details

NewAge, Inc. (NASDAQ: NBEV) develops and distributes a portfolio of healthy products primarily through a direct-to-consumer (D2C) business model via a network of brand partners and distributors in more than 50 countries. Its products are grouped into three categories: health and wellness, healthy appearance, and nutritional performance. It boasts a worldwide network of over 400,000 exclusive independent brand partners. More than 72% of the company's sales, including auto-delivery subscriptions, is ordered and fulfilled online, and over 85% of its items are delivered straight to customers' homes. As of August 25, 2021, the company's market capitalization stood at USD 248.95 million.

Launching App for Independent Distributors: On August 6, 2021, NBEV and Verb Technology Company, Inc., a leader in interactive video-based digital applications, announced a partnership to launch the NewAge Share app, an interactive video-based demand generation solution, to help its global brand partners and independent distributors increase customer engagement and sales productivity.

Management Changes: On July 21, 2021, NBEV announced the immediate hiring of Kevin Manion as its CFO. Mr. Manion was the CFO for Calavo Growers, a fresh food firm, before joining NBEV.

H1FY21 Results: The company reported a sharp uptick of 97.54% in net revenues to USD 249.56 million during H1FY21 (ended June 30, 2021) compared to USD 126.33 million during H1FY20, primarily due to the acquisitions of ARIIX and Aliven. NBEV witnessed a decline in net losses to USD 0.40 million during H1FY21, vs. USD 21.17 million during H1FY20. As of June 30, 2021, the company had cash and cash equivalents of USD 80.92 million and a total debt of USD 47.72 million.

Key Risks: Tahitian Noni Juice, TruAge Max, Nutrifii, and Slenderiiz accounted for over 70% of NBEV's total sales in FY20. As a result, any decrease in demand for these items and intense competition in the sector in which NBEV competes might harm the company's financial performance. Furthermore, NBEV relies on a single production plant in Tahiti for noni puree used in all noni-based products. As a result, any interruption in the manufacturing process might negatively influence the company's operations.

NBEV Daily Technical Chart (Source: REFINITIV)

Stock Recommendation: NBEV stock price fell 47.80% in the past nine months and is currently leaning towards the lower band of its 52-week range of USD 1.53 to USD 4.55. The stock is currently trading below its 50 and 200 DMA levels, and its RSI Index is at 38.23. On technical indicators, NBEV's daily chart made a bullish reversal trend on August 19, 2021, with decreasing volumes indicating a further downside trend. Also, a shooting star candlestick pattern was seen in the 21 SMA weekly charts, followed by the confirmation candle, indicating a bearish grip with a weak structure.

Considering the technical indicators, significant fall in the stock price, and associated risks, we recommend a "Sell" rating on the stock at the closing price of USD 1.78, down 2.20% as of August 25, 2021.

* All forecasted figures and Industry Information have been taken from REFINITIV.

* The reference data in this report has been partly sourced from REFINITIV.

Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.